NO168580C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-furanethanaminer - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-furanethanaminer

Info

Publication number
NO168580C
NO168580C NO855352A NO855352A NO168580C NO 168580 C NO168580 C NO 168580C NO 855352 A NO855352 A NO 855352A NO 855352 A NO855352 A NO 855352A NO 168580 C NO168580 C NO 168580C
Authority
NO
Norway
Prior art keywords
furanethanamines
methylene
preparation
therapeutic active
active beta
Prior art date
Application number
NO855352A
Other languages
English (en)
Norwegian (no)
Other versions
NO168580B (no
NO855352L (no
Inventor
Thomas M Bargar
Jr Robert Broersma
James R Mccarthy
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO855352L publication Critical patent/NO855352L/no
Publication of NO168580B publication Critical patent/NO168580B/no
Publication of NO168580C publication Critical patent/NO168580C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/36Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Paper (AREA)
NO855352A 1984-12-31 1985-12-30 Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-furanethanaminer NO168580C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68762784A 1984-12-31 1984-12-31

Publications (3)

Publication Number Publication Date
NO855352L NO855352L (no) 1986-07-01
NO168580B NO168580B (no) 1991-12-02
NO168580C true NO168580C (no) 1992-03-11

Family

ID=24761163

Family Applications (1)

Application Number Title Priority Date Filing Date
NO855352A NO168580C (no) 1984-12-31 1985-12-30 Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-furanethanaminer

Country Status (19)

Country Link
EP (1) EP0186915B1 (fi)
JP (1) JPS61161275A (fi)
KR (1) KR900003398B1 (fi)
CN (1) CN1007247B (fi)
AT (1) ATE55379T1 (fi)
AU (1) AU585922B2 (fi)
CA (1) CA1245228A (fi)
DE (1) DE3579143D1 (fi)
DK (1) DK163665C (fi)
ES (1) ES8701744A1 (fi)
FI (1) FI84822C (fi)
GR (1) GR853147B (fi)
HU (1) HU193620B (fi)
IE (1) IE58188B1 (fi)
NO (1) NO168580C (fi)
NZ (1) NZ214697A (fi)
PH (1) PH21981A (fi)
PT (1) PT81771B (fi)
ZA (1) ZA859890B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293511C (en) * 1986-12-23 1991-12-24 James R. Mccarthy Allenyl amines
US4847288A (en) * 1986-12-23 1989-07-11 Merrell Dow Pharmaceuticals Inc. Allenyl amines
NZ223583A (en) * 1987-02-26 1990-02-26 Merrell Dow Pharma 2- or 3-thienyl-or-furyl-2-propyn-1-amines and antihypertensive compositions
CN112441934B (zh) * 2020-11-25 2022-04-22 华南理工大学 一种卤代氧杂烯丙基胺类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
NZ223583A (en) * 1987-02-26 1990-02-26 Merrell Dow Pharma 2- or 3-thienyl-or-furyl-2-propyn-1-amines and antihypertensive compositions

Also Published As

Publication number Publication date
FI855159A (fi) 1986-07-01
FI855159A0 (fi) 1985-12-27
NO168580B (no) 1991-12-02
IE58188B1 (en) 1993-07-28
DK607685A (da) 1986-07-01
KR900003398B1 (ko) 1990-05-18
KR860004852A (ko) 1986-07-14
EP0186915A3 (en) 1987-03-25
NZ214697A (en) 1988-10-28
FI84822B (fi) 1991-10-15
IE853327L (en) 1986-06-30
ZA859890B (en) 1987-06-24
JPS61161275A (ja) 1986-07-21
DK607685D0 (da) 1985-12-30
AU585922B2 (en) 1989-06-29
DE3579143D1 (en) 1990-09-13
HU193620B (en) 1987-11-30
NO855352L (no) 1986-07-01
EP0186915B1 (en) 1990-08-08
DK163665B (da) 1992-03-23
EP0186915A2 (en) 1986-07-09
CN1007247B (zh) 1990-03-21
ATE55379T1 (de) 1990-08-15
GR853147B (fi) 1986-04-29
ES550569A0 (es) 1986-12-01
ES8701744A1 (es) 1986-12-01
DK163665C (da) 1992-09-07
CN85109441A (zh) 1986-08-13
FI84822C (fi) 1992-01-27
PH21981A (en) 1988-05-02
PT81771A (en) 1986-01-02
AU5172685A (en) 1986-07-10
PT81771B (pt) 1987-11-11
HUT40093A (en) 1986-11-28
CA1245228A (en) 1988-11-22

Similar Documents

Publication Publication Date Title
DK586085D0 (da) Piperazinderivater og fremgangsmaade til deres fremstilling
ES2065881T3 (es) Nuevos inhibidores de dopamina beta-hidroxilasa.
NO173651C (no) Analogifremgnagsmaate ved fremstilling av terapeutisk aktive benzodiazepinanaloger
FR2434802A1 (fr) Oxime-carbamates et carbonates utiles pour la protection des cultures
ES2139669T3 (es) Nuevos derivados triciclicos de indan-2-mercaptoacetilamida 2-substituidos utiles como inhibidores de la encefalinasa.
NO168580C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-furanethanaminer
FI893163A (fi) Menetelmä 19-hydroksylaasi-inhibiittoreina käyttökelpoisten 19-substituoitujen progesteronijohdannaisten valmistamiseksi
NO884367D0 (no) Fremgangsmaate for fremstilling av nye aminoalkylsubstituerte heterocykliske svovelforbindelser.
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
ES8703866A1 (es) Un procedimiento para preparar una amina alilica
ES8400443A1 (es) Mejoras introducidas en un procedimiento para la preparacion de hidroximidatos y tiolhidroximidatos heterobiciclicos y derivados ester carbamato de lso mismos.
DK46884D0 (da) 5-aminomethyl-imidazol-1-yl-1,3-dialkyl-1h-pyrazol-4-yl-aroyl-methanoner,fremgangsmaade til deres fremstilling samt deres anvendelse